Interactive Transcript
0:00
So let's talk about random nodules again, I talked about
0:03
before, these are tropic nodules, hematogenous.
0:06
And so again,
0:07
they do not respect the secondary pulmonary lo anatomy.
0:11
So here is a diagram of the right lower lobe,
0:14
which I don't know whether it'd be proud or ashamed of this.
0:16
You know, I, I created this myself.
0:18
Uh, this was a little bit while ago, uh, when I thought
0:21
that maybe I could be an artist,
0:22
but as you can tell, I should probably stick to my day job.
0:24
But here's my diagrammatic
0:26
representation on the right lower lobe.
0:27
So these random nodules, again, they don't care.
0:29
They don't care what the in lab or SEP are.
0:31
They don't care what the subpleural lung is.
0:33
They're just gonna go wherever they want.
0:35
And so when these random nodules are profuse enough,
0:38
they will involve the subpleural lung
0:40
because again, even subpleural lung needs blood.
0:42
And so blood goes there.
0:43
Random nodules will go there
0:45
because random nodules are from hematogenous spread.
0:48
And so here's a real life example here.
0:50
This is a MIP of the right upper lobe.
0:52
We see beautiful examples of these random nodules.
0:55
Some are closer together, some are further apart.
0:58
So these are truly entropic.
1:00
There's no rhyme
1:01
or reason why these nodules are where they are.
1:04
And very commonly with hematogenous metastases,
1:07
and I'm sure you you guys remember this, some
1:09
of these nodules can be bigger than others.
1:10
So some are, there are variable sizes.
1:12
'cause presumably those mets have gone
1:13
there at variable times.
1:15
They're growing perhaps even at different rates.
1:17
Differential diagnosis, again,
1:19
it's dichotomous hematogenous infection
1:21
or hemat autogenous metastases very commonly.
1:24
Here's an example of someone with histoplasmosis coronal
1:27
plane on the right lung.
1:29
This is why you use MIPS on mips.
1:31
Very easy to see that these nodules are in tropic.
1:34
They are, some are closer together, some are further apart.
1:37
These random nodules will involve a subpleural lung.
1:39
'cause again, subpleural lung needs blood to survive.
1:41
So you'll see random nodules there.
1:43
This, this patient with disseminated histo histoplasmosis.
1:46
Another patient here. This patient has thyroid
1:48
cancer, thyroid metastases.
1:49
We see these nodules, they look random there,
1:51
but don't stop there.
1:53
Look at the mips. MIPS are so, so much easier.
1:56
So these are truly tropics.
1:57
Some are closer together, some are very far apart.
1:59
They're all over the place.
2:00
Variable sizes, obviously the kicker would be if the patient
2:03
had a history of something that spreads to the lungs.
2:06
And this patient had thyroid cancer, as I alluded to
2:08
before, again, use mips.
2:10
Quite helpful. Another example here,
2:14
this patient had ary tuberculosis.
2:16
I think you can see the fine
2:17
nodularity all throughout the lungs.
2:19
Let's go ahead and blow that up.
2:21
This fine nodularity along the fissures.
2:23
Truly a random pattern here.
2:24
They're all throughout the lungs.
2:27
Another example here, this patient also looks very similar,
2:30
looks to have a ary pattern.
2:32
Here's the MIB in that patient. Beautiful pattern here.
2:35
This is actually a nice little story here.
2:36
This, um, so Miller tuberculosis, we all know
2:39
how you get tuberculosis,
2:40
but this is actually something else.
2:43
So this patient actually had history of bladder cancer.
2:47
And this is a case, this case I was shared with me by Dr.
2:49
Sak PVA from University
2:51
of Washington when actually when I was a resident,
2:53
which now seems like eons ago.
2:55
And so this patient had bladder cancer.
2:57
And one of the things that they do
2:58
For, for superficial bladder cancers is
3:00
that they will actually inject, um, a solution of m bovis,
3:04
microbacterial bovis into the bladder.
3:07
'cause it causes a local superficial inflammatory
3:12
reaction within the bladder wall.
3:13
And so it's like, it's probably like the first,
3:16
maybe not the first, but one of the earliest, uh,
3:18
utilization of like, almost like an immunotherapy.
3:20
You're making the body inflame
3:23
so it attacks cancer cells, right?
3:25
So right now in that setting, it's maybe a little bit more,
3:28
uh, indiscriminate because it's just attacking the whole
3:30
superficial lining causing that inflammation.
3:32
But you're trying to activate the, the inflammatory system
3:35
of the body, the immune system of the body
3:37
to attack those cancer cells in,
3:39
in early superficial bladder cancer.
3:42
And so in this patient,
3:43
what happened was when they're putting the catheter in, uh,
3:46
through the urethra, they got a little bit of blood back.
3:48
So it was probably a, a little bit, uh, traumatic there.
3:50
So they may have hurt the mucosa,
3:53
but they had already injected that solution.
3:56
If this patient came into the ED like a week
3:58
or two later, short of breath, they got a CT scan
4:00
and they had all these random
4:02
nodules all throughout the lungs.
4:03
So this is disseminated hematogenous m bovis infection.
4:08
So, um, I, this is probably the third case I've seen.
4:11
So I think it does happen from time to time.
4:13
I don't know how common that is still to use m bovis
4:17
for these superficial, uh, bladder cancers or,
4:20
or, or treatment of that.
4:21
But bottom line, this,
4:23
that just just proves the point hematogenous infection can
4:26
spread with this random diffuse nodule lung disease
4:29
morphology.